The authors of this paper conclude that compared with pravastatin, treatment with higher potency statins, especially atorvastatin and simvastatin, might be associated with an increased risk of new onset diabetes.
Latest research
Published 21 May 2013
Published 14 May 2013
Published 13 May 2013
Published 10 May 2013
Published 3 May 2013
Published 2 May 2013
Published 30 April 2013
Published 30 April 2013
THIS WEEK'S POLL
Research news
22 May 2013
22 May 2013
Minerva
22 May 2013
22 May 2013
15 May 2013
15 May 2013
8 May 2013
Published 16 May 2013
Published 14 May 2013
Published 9 May 2013









